Before & After: Setting Realistic Tirzepatide Expectations The ideal candidate for tirzepatide therapy is typically someone with a BMI of 30 or higher, or a BMI of 27 or higher accompanied by weight-related comorbidities such as hypertension, high cholesterol, insulin resistance, or type 2 diabetes
The subcutaneous injection technique is the same
Dehydration, eating less, or blood sugar shifts often cause them
The weight loss achieved through Ozempic can improve the menstrual cycles regularity and ovulation frequency, thus enhancing fertility prospects
Sessions happen in comfortable, clean medical environments meeting strict standards
Rosenthal fears this lack of affordability will open the door to greater differences in health outcomes across patient groups